BVS · Bioventus Inc.
$11.81
+0.33 (+2.87%)
At close · Jul 24
Market Cap
$985.71M
Shares
83.53M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-05-21 | — | |
| 8-K | 2026-05-06 | — | |
| 10-Q | 2026-05-06 | 2026-03-28 | |
| DEF 14A | 2026-04-22 | 2025-12-31 | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-03-05 | — | |
| 8-K | 2025-11-17 | 2025-11-14 | |
| 10-Q | 2025-11-04 | 2025-09-27 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-08-06 | 2025-06-28 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-08-04 | 2025-07-31 | |
| 8-K | 2025-07-31 | 2025-07-30 | |
| 8-K | 2025-06-04 | 2025-06-03 | |
| 10-Q | 2025-05-06 | 2025-03-29 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-22 | 2024-12-31 | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-03-11 | — | |
| 8-K | 2025-01-03 | 2024-12-31 | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-28 | |
| 8-K | 2024-10-04 | 2024-09-30 | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-29 | |
| 8-K | 2024-07-19 | — | |
| 8-K | 2024-06-21 | 2024-06-19 | |
| 8-K | 2024-06-17 | 2024-06-11 | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-30 | |
| DEF 14A | 2024-04-26 | 2024-06-11 | |
| 10-K | 2024-03-12 | 2023-12-31 | |
| 8-K | 2024-03-12 | — | |
| 8-K | 2024-01-19 | 2024-01-18 | |
| 8-K | 2024-01-12 | 2024-01-09 | |
| 8-K | 2023-12-21 | 2023-12-19 | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-07-01 | |
| 8-K | 2023-06-09 | 2023-06-07 | |
| 8-K | 2023-05-26 | 2023-05-22 | |
| 8-K | 2023-05-16 | — | |
| 8-K | 2023-05-16 | 2023-05-10 | |
| 10-Q | 2023-05-16 | 2023-04-01 | |
| 8-K | 2023-05-11 | — | |
| DEF 14A | 2023-04-27 | 2023-06-07 | |
| 8-K/A | 2023-04-11 | 2023-04-03 |
Showing 1–50 of 100 filings
Key facts
CIK
1665988
CUSIP
09075A108
13F (30d)
16 filings
16 filers
Visit website
Investor relations